Literature DB >> 10974412

Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer.

S Ishigami1, S Natsugoe, K Tokuda, A Nakajo, C Xiangming, H Iwashige, K Aridome, S Hokita, T Aikou.   

Abstract

Intratumoral natural killer cells (NKC) and dendritic cells (DC) may affect the clinical features of various gastrointestinal cancers. However, the relationship between intratumoral NKC and DC remains unclear. We examined 169 patients with gastric cancer who underwent gastrectomy at Kagoshima University Hospital. Immunohistochemical staining of CD57 and S-100-protein was performed to evaluate NKC and DC infiltration, respectively. A total of 25 areas containing pericancerous tissue were selected for determining the number of NKC and DC under high power microscopy (x400). Patients were classified into two groups according to NKC and DC population. Intratumoral lymphocytic infiltration was also calculated in 15 areas with a high power (x400) objective. The degree of NKC and DC infiltration was gradually decreased according to the progression of nodal involvement. Patients with many NKC infiltration had a lower positivity of lymph node metastasis and lymphatic invasion than patients with little NKC infiltration. DC infiltration was also negatively correlated with depth of invasion, lymph node metastasis and curativity. DC infiltration was positively correlated with lymphocytic infiltration (P=0.01. r=0.6). The 5-year survival rates of patients with many NKC infiltration and patients with DC many infiltration were 75 and 78%, respectively, both of which were significantly better than that of patients with little NKC and DC infiltration (P<0.05). NKC may be activated without DC or intratumoral lymphocytes. Intratumoral NKC may act as an independent immunologic effector against tumor cells, unlike DC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10974412     DOI: 10.1016/s0304-3835(00)00542-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  49 in total

1.  Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance.

Authors:  Simon Pernot; Magali Terme; Nina Radosevic-Robin; Florence Castan; Cécile Badoual; Elie Marcheteau; Fréderique Penault-Llorca; Olivier Bouche; Jaafar Bennouna; Eric Francois; Francois Ghiringhelli; Christelle De La Fouchardiere; Emmanuelle Samalin; Jean Baptiste Bachet; Christophe Borg; Valérie Boige; Thibault Voron; Trevor Stanbury; Eric Tartour; Sophie Gourgou; David Malka; Julien Taieb
Journal:  Gastric Cancer       Date:  2019-07-02       Impact factor: 7.370

2.  Intratumoral natural killer cells show reduced effector and cytolytic properties and control the differentiation of effector Th1 cells.

Authors:  Sourav Paul; Neeraja Kulkarni; Girdhari Lal
Journal:  Oncoimmunology       Date:  2016-09-20       Impact factor: 8.110

Review 3.  NK cells: key to success of DC-based cancer vaccines?

Authors:  Eva Lion; Evelien L J M Smits; Zwi N Berneman; Viggo F I Van Tendeloo
Journal:  Oncologist       Date:  2012-08-20

Review 4.  Immunoregulatory role of B7-H1 in chronicity of inflammatory responses.

Authors:  Haidong Dong; Xianming Chen
Journal:  Cell Mol Immunol       Date:  2006-06       Impact factor: 11.530

Review 5.  Trial watch: Dendritic cell-based anticancer therapy.

Authors:  Norma Bloy; Jonathan Pol; Fernando Aranda; Alexander Eggermont; Isabelle Cremer; Wolf Hervé Fridman; Jitka Fučíková; Jérôme Galon; Eric Tartour; Radek Spisek; Madhav V Dhodapkar; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-21       Impact factor: 8.110

6.  Gastric cancer patients have elevated plasmacytoid and CD1c+ dendritic cells in the peripheral blood.

Authors:  Weihuang Liu; Jie Zhao; Qiaoqi Li; Qiaona Wang; Ying Zhou; Zan Tong
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

7.  Lymphatic metastasis and nm23H1 genetic instability in Chinese colon cancer patients.

Authors:  Zhi-Hong Su; Ji-Cheng Li
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

8.  Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications.

Authors:  Natalia Lapteva; April G Durett; Jiali Sun; Lisa A Rollins; Leslie L Huye; Jian Fang; Varada Dandekar; Zhuyong Mei; Kimberley Jackson; Juan Vera; Jun Ando; Minhtran C Ngo; Elaine Coustan-Smith; Dario Campana; Susann Szmania; Tarun Garg; Amberly Moreno-Bost; Frits Vanrhee; Adrian P Gee; Cliona M Rooney
Journal:  Cytotherapy       Date:  2012-08-17       Impact factor: 5.414

9.  Bone marrow-derived dendritic cells pulsed with tumor lysates induce anti-tumor immunity against gastric cancer ex vivo.

Authors:  Yan-Lin Li; Yu-Gang Wu; Yong-Qing Wang; Zhong Li; Rong-Chao Wang; Liang Wang; Yan-Yun Zhang
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

10.  Dendritic cells in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Yuri V Bobryshev; Dinh Tran; Murray C Killingsworth; Michael Buckland; Reginald V N Lord
Journal:  J Gastrointest Surg       Date:  2008-08-07       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.